Dichlorphenamide ( DrugBank: Dichlorphenamide )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 114 | Non-dystrophic myotonia syndrome | 1 |
114. Non-dystrophic myotonia syndrome
Clinical trials : 13 / Drugs : 19 - (DrugBank : 5) / Drug target genes : 18 - Drug target pathways : 10
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00004802 (ClinicalTrials.gov) | June 1992 | 24/2/2000 | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders | Paralysis, Hyperkalemic Periodic;Hypokalemic Periodic Paralysis;Paramyotonia Congenita | Drug: dichlorphenamide | National Center for Research Resources (NCRR) | Ohio State University | Completed | 10 Years | 75 Years | Both | 64 | Phase 3 | NULL |